Focus Stocks
New Ratings
Published on Friday, 08 June 2012 08:15 Written by Christian Paolinetti
New York, June 8th (TradersHuddle.com) - Pre-market new initiations and ratings.
Neonode (NASDAQ:NEON) was initiated with a Buy and a target price of $9 at Cantor Fitzgerald.
Ligand Pharmaceuticals (NASDAQ:LGND) was initiated with a Buy and a target price of $19 at Cantor Fitzgerald.
EMCOR Group (NYSE:EME) was initiated with an In-line rating and a target price of $30 at Imperial Capital.
Cypress Semiconductors (NASDAQ:CY) was initiated with a Sell and a target price of $11 at Cantor Fitzgerald.
Dick's Sporting Goods (NYSE:DKS) was initiated with Equal Weight at Morgan Stanley.
Fox Chase Bancorp (NASDAQ:FXCB) was initiated with a Market Perform at Keefe Bruyette.
Related Articles
- DICK'S Sporting Goods Announces Grand Opening Celebration at Cordova Mall in Pensacola, FL
- DICK'S Sporting Goods Announces Grand Opening Celebration at East Washington Place in Petaluma, CA
- DICK'S Sporting Goods' Management to Present at the William Blair Annual Growth Stock Conference on June 11th
- DICK'S Sporting Goods to Webcast Annual Stockholders' Meeting on June 5th
- DICK'S Sporting Goods' Management to Present at the Citi Global Consumer Conference on May 30th
- DICK'S Sporting Goods Reports First Quarter Results
- DICK'S Sporting Goods First Quarter Results Call Scheduled for May 21st
- Andre J. Hawaux to join DICK's Sporting Goods as Executive Vice President - Finance, Administration and Chief Financial Officer
- Critical Alerts For Merck, America Movil, Dick's Sporting Goods, US Airways, and Royal Gold Released By InvestorsObserver
- First Field & Stream Specialty Store to Open Fall 2013
Related Partner Headlines
- Benzinga's Volume Movers - Benzinga
- Ligand Pharma, Glaxo Confirm PROMACTA Receives FDA Ok for New Indication - Benzinga
- Ligand Pharma, Glaxo Confirm PROMACTA Receives FDA Ok for New Indication - Benzinga
- Ligand Pharma Announces Preclinical Data for LG-7501 - Benzinga
- Deca Positions for Ramp; Names Iain Meikle as Managing Director of Philippines Operations - Benzinga
- Neonode® Signs License Agreement with One Laptop Per Child - Benzinga
- Ligand Partner GlaxoSmithKline Announces Priority Review for Supplemental New Drug Application for Promacta® for the Treatment of Thrombocytopenia in Adult Patients with Chronic Hepatitis C Infection - Benzinga
- eBay, F5 Networks: Tech Winners & Losers - TheStreet.com
- Neonode® Signs Long-Term License Agreement with Alpine for Next Generation In-Vehicle Touch Infotainment Systems - Benzinga
- EMCOR Group Inc. Stock Downgraded (EME) - TheStreet.com
What’s the next under-$10 stock that could be ready to skyrocket? Find out now when you join David Peltier at Stocks Under $10.
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
Stock Market
Loading
